Related Experiment Video
Updated: Sep 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
National surveillance for meningococcal disease in Japan, 1999-2014
Munehisa Fukusumi1, Hajime Kamiya2, Hideyuki Takahashi3
1Field Epidemiology Training Program (FETP), National Institute of Infectious Diseases, Tokyo, Japan; Department of Epidemiology for Infectious Diseases, Osaka University, Graduate School of Medicine, Japan.
Abstract:
We summarize the epidemiology of Japanese meningococcal disease with serogroup distribution. One hundred seventy-eight meningococcal meningitis cases were reported from April 1999 to March 2013 to the national surveillance system. From April 2013, bacteremia was added to the condition of reporting invasive meningococcal disease (IMD). Since then, 59 IMD cases were reported by the end of 2014. Approximately two thirds of the cases were male and the median age was 56years (range: 0-93years). Only 3% of the cases were <5years old. One third of reported cases were meningitis and the others were bacteremia. The annual incidence (2014) for IMD was 0.028 per 100,000 and case fatality rate (CFR) was 19%. Serogroup Y (42%) was the most dominant serogroup, followed by C (12%), B (7%) and W (3%). Even though the number of reported cases has increased after the amendment of reporting requirements, the incidence of IMD is still low in Japan. Underreporting may play a role in this low incidence. Improving on the limitations of the surveillance system is necessary to capture the true epidemiology and accurate serogroup distribution of IMD cases in Japan, which is essential for making effective recommendations on newly licensed vaccine.
Insights
Japanese meningococcal disease (IMD) remains rare, with serogroup Y dominating cases. Enhanced surveillance is crucial for accurate epidemiology and vaccine recommendations.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health Surveillance
Background:
- Invasive meningococcal disease (IMD) reporting in Japan was amended in April 2013 to include bacteremia.
- Prior to April 2013, only meningococcal meningitis cases were reported.
Purpose of the Study:
- To summarize the epidemiology and serogroup distribution of IMD in Japan.
- To assess the impact of amended reporting requirements on IMD case detection.
Main Methods:
- Analysis of national surveillance data from April 1999 to December 2014.
- Inclusion of both meningococcal meningitis and bacteremia cases from April 2013 onwards.
Main Results:
- From April 1999 to March 2013, 178 meningitis cases were reported. From April 2013 to December 2014, 59 IMD cases (meningitis and bacteremia) were reported.
- The median age of IMD cases was 56 years, with 66% being male. Only 3% of cases were under 5 years old.
- Serogroup Y was the most prevalent (42%), followed by C (12%), B (7%), and W (3%). The annual incidence in 2014 was 0.028 per 100,000, with a case fatality rate of 19%.
Conclusions:
- Despite increased reporting, IMD incidence in Japan remains low, potentially due to underreporting.
- Serogroup Y is the dominant cause of IMD in Japan.
- Improvements in surveillance are needed to accurately capture IMD epidemiology and serogroup distribution for effective vaccination strategies.
Related Concept Videos
Investigation of Disease Outbreaks
Rocky Mountain Spotted Fever
Bacterial Meningitis
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

